Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000493237 | SCV000583102 | likely pathogenic | not provided | 2016-03-04 | criteria provided, single submitter | clinical testing | The c.1 A>C variant in the GYS1 has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. This variant alters the initiator Methionine codon, and the resultant protein would be described as p.Met1?" using a question mark to signify that it is not known if the loss of Met1 means that all protein translation is completely prevented or if an abnormal protein is produced using an alternate Met. Therefore, we interpret c.1 A>C to be a likely pathogenic variant; however, the possibility that it is benign cannot be excluded." |
Labcorp Genetics |
RCV001345596 | SCV001539727 | uncertain significance | Glycogen storage disease due to muscle and heart glycogen synthase deficiency | 2022-06-13 | criteria provided, single submitter | clinical testing | This sequence change affects the initiator methionine of the GYS1 mRNA. The next in-frame methionine is located at codon 9. This variant is present in population databases (rs748334413, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with GYS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 430320). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV001345596 | SCV002023443 | likely pathogenic | Glycogen storage disease due to muscle and heart glycogen synthase deficiency | 2020-03-06 | criteria provided, single submitter | clinical testing |